Please login to the form below

Not currently logged in


This page shows the latest PrEP news and features for those working in and with pharma, biotech and healthcare.

EMA launches rolling review of J&J’s COVID-19 vaccine

EMA launches rolling review of J&J’s COVID-19 vaccine

J&J is also in talks with other global health regulatory authorities as it preps regulatory review processes for the COVID-19 vaccine to be used during the pandemic response period.

Latest news

More from news
Approximately 3 fully matching, plus 38 partially matching documents found.

Latest Intelligence

  • Redefining communications excellence Redefining communications excellence

    In 2016, Gilead broke its self-enforced moratorium on the marketing of Truvada for PrEP, its drug for preventing HIV. ... A survey run in 2014 and 2015 found two-thirds of primary care physicians had never discussed Truvada for PrEP with their patients.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • World AIDS Day 2018: Fighting the stigma surrounding HIV

    14. Both pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) drugs may prevent infection developing. ... PrEP (pre-exposure prophylaxis). Available at: . Accessed November 2018. NHS. Can post-exposure prophylaxis (PEP) stop me getting HIV?

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...